NAD+ · 500 mg vial
NAD+ appears in 500 mg and 1000 mg formats in the wider research-material directory. Listed specification: 500 mg.
Explore individual compounds, blends and separate-vial combinations. Compare specifications and follow each item to its reference guide.
NAD+ appears in 500 mg and 1000 mg formats in the wider research-material directory. Listed specification: 500 mg.
Neuroxelin is included in the blend collection with a 48 mg vial reference. Listed specification: 48 mg.
Ovagen is indexed as a separate 20 mg catalog reference with an individual identity record. Listed specification: 20 mg.
Oxytocin is listed here in 5 mg and 10 mg reference formats. Listed specification: 10 mg.
Oxytocin is listed here in 5 mg and 10 mg reference formats. Listed specification: 5 mg.
PE-22-28 has a 10 mg directory entry. Both numeric groups are retained in the catalog name. Listed specification: 10 mg.
PEG MGF is listed in a 2 mg format and is separated from the non-PEG MGF entry. Listed specification: 2 mg.
Pinealon is presented as a named 20 mg reference rather than a generic brain-research product. Listed specification: 20 mg.
PNC-27 appears as a dedicated 30 mg entry in the research-material catalog. Listed specification: 30 mg.
Prostamax is recorded as a 20 mg named-material reference. Listed specification: 20 mg.
PT-141 has a 10 mg single-item entry and a separately indexed combination with Melanotan II. Listed specification: 10 mg.
This stack lists PT-141 and Melanotan II as separate 10 mg components. Listed specification: 10 mg + 10 mg separate vials.